How to manage primary pulmonary hypertension: Giving hope to patients with a life-threatening illness

Mark J. Ricciardi, Melvyn Rubenfire*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Primary pulmonary hypertension presents a challenge to practicing physicians, in both diagnosis and management. Exposure to anorexigens and complaints of dyspnea and fatigue should prompt careful physical examination and Doppler echocardiography to assess patients for pulmonary hypertension. The burden on office practitioners is heavy, considering how often fatigue and dyspnea are reported, but the key is recognizing when these findings are out of proportion to the patient's well appearance. The discovery of epoprostenol therapy has revolutionized the approach to primary pulmonary hypertension. It has markedly improved quality of life and extended survival in patients with the condition, and it has changed the physician's role from providing emotional support to dying patients to providing management of a chronic disease.

Original languageEnglish (US)
Pages (from-to)45-56
Number of pages12
JournalPostgraduate Medicine
Volume105
Issue number3
DOIs
StatePublished - Jan 1 1999

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'How to manage primary pulmonary hypertension: Giving hope to patients with a life-threatening illness'. Together they form a unique fingerprint.

Cite this